N f 1 ^ T W l J l S i n 9 U n T 5 ^ € 1 1 f M 1 l J l 2 i m * W l J f l f l f 1

m?i^aji4i^ii4uiiJia¥n^mtt^fii?jjwiJi£j H I V / A I D S N Ivftuvi I f i i u E J i ^ i u hift qj qj u

( A n t i r e t r o v i r a l Drug) l l j l 5 ^ I A | e j i u i c i m ; f n ? f U o l ' f f C

2. 9iErw9 iminpi ifinii[m9i^^tii^ii4m9iJ¥iiiJi^^i^4liifliJis;tiiBiii^j4in?w

(^itivtii^mnj^ 11^1.114)

1. ^Qwa-a™

milN^UI^IVIufui f lTn^md' l fn i l J JWl l ie J H I V / A I D S wl l ld^lpi l 'ue jnPl l l j ' l l I tT (Antiretroviral Drug)

l - u l i ^ r j m i n f i n O T i i t u o f f T f l

2. i s ^ a s n a i ^ ^ i m ' u m i lo imu ( i u n n f i j j 2553 - 3 1 ^cnfijj 2553)

imvf (AIDS; Acquired Immunodeficiency Syndrome) l l Ju 1 l f l^mPlTnnmiS?) l fs l l l t r f a Human

Immunodeficiency Virus (HIV) 1 ims 2 d l u l n d w i J i e j l l f l l Q P l f f n l s i i f l l f Q l Q I f l g l l f l J f ) ^ 1 IflO'Mll

i i t ) - 3 i i j f n i i p i i f 9 f i ! ' ^ i i i n l ' u i l f i . f t . 1981 IwTfioi ini i J jmfrl^flQif i i in ja^fi iQiinMijn 'ul i f iapici^ ^'aini^a

qj qj q

fJ-lEjlamtr (Opportunistic Infections; OIs) 1JlllJf[9^inni1lllll]QOtl3S;9?111ini1t^ollPl'U9^wdlO'MmiJ?14

[mxinmiuM vi.fi. isn - 30 lAiqfriniyv! i^.ft. 2549 tihniMmBu 305,318 mi mi\iiimm-]mmc\z 70

nv\zmmm^mv\z 30 wiJioiTQulvidgiq 25 - 39 i l (fgofisi 67.43) wiJiomngnq'ugon'in 15 iJ nrnm^z

4.19 wil ioiaoas 44.18,20.87 5.92 CBiOTiul'n^riiliJ m n ^ i n i imsii-3-3i"u mumm m-imiwim

leim^ivn^mflfd^j j 'NiJBinfi^tt^ (wmz 83.86) Sno -3 iV!N^fi i^0in!nnfnf i f ia i^ j j in^OT(i0Ocis 38.87)

ImmmzhnimnmyMinMim (leoiis 10.96) wiliej^mejSi^ifl'n^viu?! 85,123 m

mm%^limiinmhnmi^mm\n\\n\m'U'U m m i H m l l l l i l Q I I t n i j j J Nucleoside Reverse Transcriptase

Inhibitors (NRTIs) 2 m<f\ IQJJnuenndjJ Non- Nucleoside Reveree Transcriptase Inhibitors (NNRTIs) 1 TfU^ 111011311

Protease Inhibitors (Pis) 1 -2 IQufl^^U 3-4=B'UPt l i o n i l HAART (Highly Active Antiretroviral Therapy) m i l l m

l i i i4 l i i tr1i4i] i )? i J i4l i J tTiJJ i inm^fi i f0i0if l9l l i i i i i^ mo^innl'uisfjs;iiinni0-3mii^i,f 0101^101 sizv if , if %

ifain-jfTQuvfuuQejlu CD^ T cell l^EjIjjSmimu^ivnu uas0^0dlv!Pfii™iIi4lpii4iuim'iii)slpiii)m^^^

iJis^SyiSmvjn^ijj s^^ilu t i l T H i n t i l u m i i n i n l-3liil=iiminii 's?iif0i0ifl0il 'Hvi3jpilili)iriii^nit) u m f l u m i a ^ i s f i i i

HiVRNAli J i^ f i i tT i J i l i i lp i j jnn^q^l i iadl i J ix^ i i^m^fTf i !)'UQ^is^ii^mi0^1llynii?ii'3!)T'^l3Jttiinifi^n!iT '^1^

(undetectable level) V(101S;^D^mil 2O-5OOcopies/iTTlims;0^1S^ll'Uyll11J114^tT?)mi^!)S;illl4llll^ IploSmillls;^!!

HFV RNA li4n?ntTinti l i4^i5T'^0n3Jt ! i t i ! ) lumiinin m0lmnfirinivli4i^v!i0fiiiin%jntTfiiviniiiii^ni4nj0^ii;iJii

nfl0j j f iuu0^ii^fnej ( i j ; ^ i i CD^mufiu) mu0fumi^5QOT9^wiJiEJ ueis; i i l i4mifif i0nuraii i) ie)V(i0fniiSt j l i^^0it)

tn(Fi^wi)nnli0ipiif0RQfjl9mtT mmiinavn^md^^ni l i J (Phan-naceutical care) PnJJ0 in^fmiJnj0-3 Strand ims^^lflJJmd'lfnilull-JTAIEJIUIfl

0 a 0 Q i i J i i i w p i i J 0 i i f i 0 n i i l l o i i n i i i l i f i l ? ) o f l Q ^ n d i 2 ; m 0 l i i w d i o l p i i ^

2

(phamiaceutical diagnosis) IVJS

^mm-ii^mit^unvmrnmi mziiVMiwm^ n maSninn^Wfi fn iu i inavn^m^wmi njw lu i J I97i Cole ims;

Emmanuelviu-ii tnm^nja^fmuliJiiwwe lijnnilloinj0^WT]-3olifiifaf^tmxSfiiiiliiidaoiJiiwijniillejn 09 m i

33Jiiiilis'vni4miifis;mil3Jl'lm?i9t'U9^ i'U9^?intnfi9iniiliJw^di2;m^m9m3''=tfni1^lTi9iuws;ijnim tn in inmu

f m u i ' i j j ^ g l u m i l w i l i i ^ f i i j i m s l u i ) 1999 Leapeimsifims; •wu'inmiSmd'^Knilu^u^iifiwiJQej mui ic ia^g^nmi

m^Qimilii'^^iJisit^al?!adi^innimsfliTutfiaa ii^mm^'immm^mw{\m^iimUIMmilninpiinniltuvn

l u m i l l t n ^ i T u l i i m m s m i ^ n i n m ^ H ^uiT?i^liimi4iJis;lejwn)a^^™iiiijnfivii^m3^Tfnii3J l ^ i l a v n ^ i ^ i i l v !

niiSnt)i^^ndiim3u!]qjvii^m^?ijli4liwmiii3raniimoifTfli^

ilfiJinmilloi^inf)1'uli^iAiminal^ ^ ^ f i

1. 'i^m^%mm^Al^v^m^»>mmii^hm^ (l\jnimwi]imnolviJj)u?is;'Hfi^i)inim'vio3^-3EJi (IvinimwiJQeiim)

m^i^nu

2. wiJioin^aimilii'^-ailistT^ainnmill'm (advereedmgreaction: ADR) i n n m i l l m l T u l i i t t

3. miliJilis^mtjmlu'^ama^irijnttrua nuii^wiJloliifniniciiliud^fj"ui51mJisinijejiliitta^ifipia^nii

m'i<f\^m^nl<f\\<f\

4. wiJ 101mJis^wijenl'iul-iim^auammvj innmim 111 ninoinja^willoli i f jnlia^

mQ-3innNii^i,?aia=Kle1liiili4^a^lloi^iia?i5i^ md^^Bni'if-^iflumfoQififypiniJonimsJiSiJM'u-iliJ'iJfifiini

ftiBiifufrnj^SuYiinYi^i^fij ^amimjJilis^SyiifimmsiPimiJilsafirioliJfinilltinmuliin ims^iJis^iCiJfniiiiiJjya

l i j m i l l ' o i l ' i i j l i i m a i j io l i i wiJ l o u n n d winotr^tTfilumii nun qj q qj q

I V

lua^Diniimifi^ma^wiJiomam iPien iTU h i t r IpiolirimiYn^iJgiiPi'ua^mufnunulifi fnoamumjfii

iDnia^wiJQEJ l^finwilioSlifiifiraafJiolamtT (Opportunistic infections; OIs) ^a^iinmiininna'u ^tfn^wfniSmi

i^i03JWTJiol^oa5iiiomwiJioin)ilTO^inofisiao^im^i)annviT4fimm l^wafi nun-^ I 3/ r I

niapiniaitronja-imiifi'yi m i i m o i wfinn-iifio^yiaifl^sm^niu TBilgupimampiilfij'Hi fmucinj9^mi"Ufiv(jjiEj m i

i j i^ni)itfis;ifiin9dn^^9ma^^fia^5i?i Miai)ijn'iii)s;Si4i|^lm^niilfioani)flmiMq^oi=5'iniiima5wa=u^^^

\ i i lmn^au?i i ie j i J inn ' i i i l i j ; low mmlnmm^mm^ivimllmmllmili liu ni'umhmmmmmiA

i i j u i ^ mami iny ip i j jmfn I^SfiinwIidiJ^wdioaiiCfiiiJJiinfjQniion^^iJia^lpiiii ITJIJ i l m i l l o i i i g f i i i q qj qj

i Jgi i^ma hmuu a i m i mtN-ailisfif^anja-aEngnij hima^tr m a mwiJiotnpifmjJiin m mzmm^^ hm lfiaoi-3

f j f i l ' a^f iP i i l fyHimilafn ims^mu^mmviSiginja^HiJiEJ l^tn^nniiN^tn^nuiiiinfiim^md^^niiiiwiJiEJ HIV/AIDS

wlnd'Mlpll 'UenlhljlQIflf (Antiretroviral Dmg) Iwli^'v^eninanTffnifuoifffl^'u mal-HmiPjimwlJlEJHIV/AIDS

wlvidl^oiifimnilw^jjtTVifrnnniTfiSn

3

ll-31^milianifni1tU01fr2lplllini1P1111)inynwi^tf l u i j •M.ff.2549, 2550, 2551, 2552, 2553lia^2554 S

?ii4iT46lno 88no 128no 124110 l33noncij; i25iTOiijanpiiJtms;1piiiioTlinT4l-iitt6i n o 88no 128noi24no 133no

i25iTOiJjdn^ii ii^o-33ui4ilyiJw^i)s ;1^iijmiiniJil ' ioow^

wiJ lom aW IPI o i ^ i y l i i ft IfiolluuTm^ilgij ^nja^niufnu^ ulifi^ioanwiTSjfiilBnia^wiJ l o l ^ n iwiJ loS liais^itf a

Riolamit(Opportunistic infections; OIs) l l 8 W i m i i n y i n a w ^ ^ 1 ^ f u a i l f l m i t m o l J N J l o l f l o a S l l 1 o l l 1 w d

l^mzmmmz%m^y\^l<A\\m'i^\^^^m^\m^\'nmm'^^ n i i 'n^l ' a^ ' i iamonia^miiniyi nw m i i m o i

wcin) i^ifi ow 9ii)i)sin 141B iJg 11 ?i 111 ain iJ tuvfi fiiijjo iia^miij m a' I I I

i)ijn-iifls5i4ftPilm^niilpioaii)C miifOfiowimiimaS Weill i-3ta

'WiJiifuii'Hutnjfni^ioinm^au mv. miinfi l i f iuviin ' i fai iQdi^iuit i^ n i a m i i n i n f i u m f n

lpioiN^i4i l i i ia^ii ipmii l i t i l i ! i i i?i i5 ' i l ioliiwi]io1^iiiWfiiJislow^4irfif)nnmil ' l(oi tmsHoiadi-3 2/ if

ilaafino wttTual^^imufni^iiiiiuptaum^'n'l^y^i 'liJ ^ 'Q if I I

1. m i w u m i m i ^ i m u m i tSmij^aiJi . i ifi l i jrii i^niJimaliiinm'iiJJtrs^in n ^ t i iims^ila-^nuilfyitTOan^fisi

inpiluis^niTOii^nin

2. muinunimni i i i ^inunm'uaijfi^'i-in I'=BI4 lanini n i t t i i ^lui^o^mm-a i 'v imi unanum^^ i m x n i i W

3. ninu^i^fiilistt^^ua^miiioui

4. trii-Jiaie^Salumiinuniinuiiauci

5. ?pini)niiiimiiiiinfiin^mOTniiu

6. in i i n i i n u iJis;i5u i mstri ilwei I 3/ 3/

fiinil mi-m -m in i l i i tn miili111J1 ^luiia^nd miu i\ i l i i n i i ^ ifu u^iuu IPI 1iiilis;lowj i ^ n

l.lN^inmonTlNUa«111141^1l4mi 10 114 tmj;iN^141imininmd^W1tl'l?f Phan-naceuticalcaie tn?imil11^1141 l l in 11

t i l n ^ u t T K m i n i w v i

2. milloi3i4liladi^SiJisiSmfnvi tmsamnwlumiininwilQO^Ci!

3. i i n i i i l cuinli4miHonjB-3wiJ lo t tzra ii4iin^i1 a^n ui mst tin l u U qj

5. wiiu^imiimi

6. friinj0-3^ii4^wiafi48ii)i4wiJgim

wttn4ami4wilgi)^^nutouiii4ivi mmif i tmwiJ - io inoin i imi boili4ficii4n Ucispnii4i4mi^i3jn)i4pi9i4pn-3<n if if i/

n w u p i i a o n ^ l o o i l n n g n o a s t a o m i i i l g u ^ mu^asimi4^ai4^^i4

1. n^uwi4minnii^imi4mi

3 / 3 / d a ^ a / i ^ ^

witrwalpiiiimm^iiwiiminnintilydi^uiii4?iai!^i^n i ^ ^ ^ ^ m i S n u n i l i 4 i s ; i i i i i m z t i z m m i m i

Ipi'uaya'Mnn^a^ i d o i i i iJii^i9i4niii]a^ni4dtuM

2. n i i i n u - i i i m n i i j j

4

i ^ i j m n t n i n i t n i -31IJQ O ^ i n Y n ^ i T f i m i u'vipmu^i^'n ims;nu1'Tf^ 111011 111111 1111 n i i u i i i i c i m d ^ i f f i i i i i S

iiniiinlpiTOi^lufiiiin?^ejin^ifid^Tmii3J (phan-naceutical diagnosis) m Q f i i m i unlii ims^ilQ^niJilqji i i^mej-iniinii

lloinj9^wi]iou^'os;iioufisi^ii-iiniiSmd^ifniliJ^i)^uaNiJi£j iTiiJiicicifia^iiniimpigifiiilii '^^ilis^tT^al^QEJi^

iJinuas5iIotTiofyTi^1piiiiniie)0jJii)i)inui^ino'$^i^

3. f i inufi iPini l is t t^^ma^nii t ie jui

3.1 m g l M w i l i o f l f n i i i m l i i l u m i l l m i r iDi i f i l lmlpiom^ci f i l 'o^ qj qj

3.2 mai la^nu tms;unl«ui]fyiiimillm^inf)flijniiWT]io^1l'ii)mmi4l^^

3.3 maila^nuitftsufiInjainnliJ-^^iJis^^^ainnmille j i^aii)m^fiuniiNiJ im\$Huen^iii l i ima?i^

3.4 maifi?iiJjim2ii)a-3nwfiiii)fifiTOia^ai4iii-30i^in^^i4niiHd qj

3.5 maiN^i4i^ii jmd^if i i i i i iWii l i4l i lpi i i i i i i^i|i i4i^iST^md[ifni i i J

3.6 m a l i i i n f i n i i i ^ ^ i 4 i i s i i i i f i i i i l i s t n u ^ i i ! ^ ^ i i Q ^ u a t i i n i l u ^ u t t n t T i i i i i i f i ^ i ^ q

4. i T i i - i i a i a - a S a l u f i i i i n i i n i i i i j j i i a i j a

i J i4 'nni ioyawi] io i i^ luui i i i i J i4^nni i i i i i i ia i i i^m^ifni i3 J tnoin^

N i J i t i m a w f i i m w i l i f j m a l i i I p i i 1111 a u f i ^ f i i i i f i i i j i m i i J i u i i m n s i i i l t u i i T O a i i i m f i ^ u i i ^ t ^ i o u l i i d ^ ^ m i s i i i i qj qj qj qj qi ej

Pre-Print ( m i v i u n i l i s i i ^ f i i i i i i f J T O i u hi^ai^?iii|^!)ina93Ji^ii^aiei^mfrOTnaiJi^iiimiio)tTwiiiNiJi£)i!Pi m a

ii iofi?iaii i iaaifi iaaai!yii^m!)inniid^^llmuas;l i i tn^a i i j j t t s^ in i i f i i i i 1 ^

5. ^iPini)niiwniiDiiiifii i i-3yid^imiiu

mt iua l lwni iS ip i^ iwni i l lo iDa^wiJ io HIV/AIDS mali iwiJ ie) lpie) i^fl i l is ;3i iSfnn ilciafiJiouas;1liNci ?ii3j^^a^nii

5.1 i i a i r i i m m n i i l l m ims^iJis^mupniufjn^a^ mjjis;?rjJDa^niillmluwiJ-itiu?ifis;iit)

5.2 f i u n i i l o m i m i l l o i l u w i l lot m tis;nt) 1J1 n u n msi t i i iauinyi i^ni i imi l fumi in ^ u t r n t n i n i i f i i v i w qj y

5.3 l i i ^ i i m s i j i i m s ^ i ) i n u i i l a i i i l u n i i l l o i i m s n i i i J g i j i ^ i l i i i i i i i i s ^ j j n i i f i i x l i n n i a ^ R i J i o ^ l o n i i

f f i l i i S Group counseling m a l i i f i i i J j i i i n N i ] i o l i J i i 0 ^ 1 i 0 i m s n i i H o i l ' i u l i i t T a d i ^ n n ? i

mr j ^ili2;tT^a n aiDin Dinon msm a ^ i i i l g i i 9i lu ain?iainiipi ^na n

5.4 S?i?iiuniilloi^a^NiJ l o m a l i i wiJ IEJIPI 01^ C i l i s ;3 i i5 n™ ilfia^in oi ms^l^wn^iii^ l i a^ni i IPIOS^PIIU qj qj

w a n i i i n u i B i n f i l CD^ma^wilifj>200ceiis/dL imsainiilii '^^iJisiT^R^iinmiHoima^wiJio a/

5.5 lua f i i lnwi f f t iwi l iE j^^i f a HIV/AIDS md^TfniDsiius;i4imillmDa^NiJiej i m s ; i j u ' n n f i ^ l u i i i i i i i j u ^ n qj qj

I I I I I V

i i i n i ^ i j i l lui i i in o i n i i m ^ I m i i o m md^'ijni!)2;iJis;mi!^iwniii « qj

a I 3 I I

11-alii a iiii4s;i4 i in o in u l i a i laaiaimi'ua^liailii 'n i l n i i K e j i ^ l^i111 m s i l n i i i n u i n u i ^ n n^a-3

6. i n u i i u n u i J ismu ims^miJ

i1i'U93Jti^1pi3Jiiiaiis;ii'iifi2iiTiilwfi maiSi i l 'ayal i jn i i i J i i f t i ja l i jamsini i i jn i iw^iJ iamniTOii J iapid '

5

i l l u l i l a d i-afl'Llis:;S'viSfn'i^

mil^imi4lfl1^fnill4flf^St?}J^imi4mi^^U?iT'u^ l UnnflU 2553 miMY\ 31 PlenflU 2553 fU llinfU119-3

^11!) fiS-ufT^iffywiJiej^fitf 9 HTV /AIDS i i n i u g ^ f i i i n m i3.oo-i6.oo u.viii i im9Sij?tPilfi i^fii inuisos;nfnin-3Su

10 t^9W md^'wrngimwilioiiuniiimiiej l i u i u i i ^ i i i i P i 133 n o li!miiN^vni2;iiiifraii?infiin^md''Kn'3'3U fif-3u

md^^ni^^^iiiwiJ 10^i^i i i l funnmil len 3 w a m i ^ f i ^ n u m i l l o i ^ ^ w a'

1. wdQofl9111jf9113Jmll)imslloi9dl^f)ri^9^3Jin?14 innmi?in?ir91l^^^13Jimstr^tmjJ Adherence ( f i l l I I 3/ I

1iiilis;ini4en^iv!9d i^fi 9 ^ 9 IT3J ittnie) l u f i T a l l o i ^ i u l i i trug^wiJQfj i i ^mi i J f i i d a mnt i i i i l is ; inuEnl'H I 3 I

tfg^fifi 9^ri i i m i ^ i m uSi?i m i t r i i w q i n n u l M i J ^ ©99 ivno^i 9fnif i i i J is iniJEnli lul i f tT9di^?i 9m g^ims

?TiJifTii9 m i l l i m g ^ f i g i f ) Adherence mY\mzviii^imwi\im<^t\z'3immz\\mm^i^^^^ 911lltfl9a'U9^ni111llJl3illll401^11l'll1tTVIlll1fyV[l 36n0 9^tlll!190c1S28.80 S3i l,ttlSPl pnU inW 1

m'^iw 1 uti?i^ilain«u9-3wiJQe)

l i u i u w i l i o d i o )

ilfijinmiiiiilisvni4£n li.n.

53

n.n.

53 53

m.Ej.

53

nf\.

53

u.o.

53

fl.f1.

53

M .

53

fl.O.

53 53

QJ

1. fmlis^nnuoil i J^i^nfn (miss time) 2 0 3 5 1 0 1 1 1 1 15 41.67

2. I l i l p i l l l l l l S i i n i i e n (iniss dose) 2 0 0 3 0 0 1 1 0 0 7 19.44

3.iiienvno 2 0 0 2 0 0 0 0 0 1 5 13.89

4. flllllS;inU01tnU'Mimilodf^ (overdose) 0 1 0 0 0 1 1 0 1 0 4 11.11

5. w i l i o l i i u i g n u i l f i 1 0 0 2 0 0 0 0 0 0 3 8.33

6. i Jamgi i 'n {lixi (iimm nlv\om'\lm

^gdlil^ii^^wispi) 0 0 0 0 1 1 0 0 0 0 2 5.56

1111 7 1 3 12 2 2 3 2 2 2 36 100.00

w i ] i o n f inolpi 1 u m i t tn l u i mzi'n mmi im g l u m i l l o i l ^ o m ^ if n i W ^ iuus;i4 ipf^fi qj q

1.1 m i 11 mz^ 111! f i u n n o i n u m i l l o i m 9I11 wiJioS 911111 u!is;^is;iiiIno ^ f n i u ^ i ^ n j u g ^ m i i i n l i s n i u qi qj u

oi90i^fiiiioluiriiitttu9iras?iem9^ u n c i n91 mzMiinoinIIIBmiilg 11 ^im9ifiPiiltuKi^i^n mnoi to *"

1.2 m i l l o i U U l i m p l l l U (Fixed-Dose Combinations) W w i l 10111 VlllOI^SPlin^l!

1.3 nii?fifiii3jniJ9^fiiiiiiiJis;iiii!0iliiSliuii4S9i490 ( I j J f i i i tnuiuf is ; 2 ^9) Tis^ifiocififiiiiiq^oifiims

n i iau i i ) i J i s i i iuo i1p i

1.4 n i i ^ ^ P i i i i ^ t i f i i m i i m J i s n i u o i ^ m i i r t r u n u S i P i i l i s I i i u n i g ^ w i l i o u ^ ' a s ; n o qj

6

1.5 nnill0iJnifuiJQejil9i4^m}Jisttijniiw{lit)u^'fis;inf)iinmmnlmImfirnvm^

1.6 mifl^lSt)^d^^in?imimmi1lllJlsyniJmnJ9^wi)ltJ (Directly Observed Treatment; DOT) l^OlRVIIslui^QlJ

inniie^mil'ninl^infiQimil'i^mej^fnnmlliiiao

1.7 imzuil-Hn^onKlij^Nilleitninind^^ifipimlilmiu

1.8 mil l l lg -n i J (Medication diaries) l^lllJ^nnniflllllS'Vll'UOllllU^'flsSoniQ^wiJQO UflSfniSlia^lflVifll

1.9 a B i n o i B f n i i n u i f f t n f n ^ o n l ' a ^ ^tT-3inij 30 0-3fnTOi§ej?r mm

m^mumfilmYim m'3^zmmlimlimmmm'n ^imvm Ritonavir ( RTV) ^a^tnulilw^iowiia^Biiu^i

(amvififl 2-8 g ffniiffii ejjr) f i i l u ' S l i o i j uijj; 'unl'Hmijm1'il'u^wum0^i)in m Ritonavir (RTV) innH^amnfifl (25

0 fnt«B?i™otT) 1 mm QidijliJlpi0ii)!)TOmliiw{)io0i^a2^'U0£j dn 2 vi^m-n ^0111010^0^01^1^^11^

iiiis 'uimimiioiliivi'uw0tlfi liinii^nmij^iyfiK^viDilfyvnmiiniiffiyifn 2 011 ttTulvidinpi^nfiEn^^a^uTJiou m

\^'\^nmmmi^^m^^^imz'3^()2vi^<f\w

2. nilimmm us n o lmiifiiiiflii2;'i-3Ufisipi?injjnniin?i0innilw '^-3ili2i?r^0f)inniiKon1fi^^

^011404110110 iNiiwiJ-iotfi^0ii^fiiifum^fnim m v i w i s i r ^ ^ (ADR) iiinmilifoi 107 014 l ^ o i i w i J i o i m o i i i o m u

3110 tmsin^0iniinji4t0O4flinoi 104014 (side effect) ^4utTPi4^iii^inw 2

^iiiw 2 iitT^4oiufii;0iniilii'^4iJisir40^in?i!)inniilloinj94WiJ-io

i i o n i i o i i i v i i i 0 i i ^ n i i t u 0inil1lJ'M4lllStT4^

0 C4 Q / « o'

i ) i i 4 i u i i w i 0 i i p i n i i f u i i o n i i o i i i v i i i 0 i i ^ n i i t u 0inil1lJ'M4lllStT4^

014 1000s

1. Co-triinoxazole Stevens-Johnson Syndrome (SJS) 2 1.869

2. Co-trimoxa/ole Maculopapularrash (MP rash) 4 3.738

3. Co-trimoxazole Nausea Vomiting (NA^) 9 8.411

4. Nevirapine (NVP) SJS 1 0.935

5.Efavirenz (EFV) Su44 nouiTi i!0uliiiiaii tifs;^4ii0O'n 29 27.103

6. Stavudine (d4T) Lipodystrophy 52 48.598

7. Zidovudine (AZT) Anemia 1 0.935

S.Lamivudine (3TC) + d4T Lactic acidosis 1 0.935

9. Anti-Tuberculosis dmgs 8 7.477

n u 107 100.00

l4!nnniiip1iij;Q4ims;ipi?iiu t r i i i i i o i l 040140011^ i)sin^0iniilij' 'W4ilis:;tT40^ii4tii4l^ 103 014 0 f i i i l i !

10Of1S; 9626

7

3. c1^f111JJf1c11^tfl^0Uyi14m(Medcation error) ^ i m n i P l l l f l l t Q l J I i m i i m m (llJf l im

wiJQejnolvijJ )mzm^^iammviwi ( lummNilioiinn) maiinom'MSiJis^yiinnT^tms^flfiiniiofiifiifiaaiJ'vii^m'uotJ

rimmnm i^uiltuvn 3 6 n o mi^-uhmz 27.07 l^iejBiimnfmjjfifn^ifiSsum^ejiiiliJ ^nijfus^nja^ansjficn^ifisav! q V

mm ummmzmmivm-iiw 3 wiJ io i in i io lmi jnniunlni l^omOTni i i i jnTJ tmviowi^^ qj q qj

msiw 3 il^m^in^flinanuaftTOiaoa'UTn^on

aramsfniuaaTOiaaaij 'vn^oi I n i J i i j (no) laocis;

l .fniJ jafn^maaUinnfnimlloinja^imYlO (prescribingerror) I m i f i

1.1 m\4mHmm 4 11.11

1.2 QsllonlsJmins^frji 6 16.67

1.3 is^ijanjJui-anja^EJiwPi 9 25.00

1.4 W^lllJTU 11 30.55

2.fmjja?nfitaoa"U!nnnis;inum?!ine)£n (dispensing emor) I m i f i

2.1 mw<f\ 3 8.33

2.2 w^ainiiui^ 2 5.56

2.3 WPlllWTU 1 2.78

n 3 j 36 100.00

4. ' w ^ ' m i s ; i i i i m i l ' H i i ? m i

4.1 ^ i p l l l l f l ^ f l l l i m i l i n o o i m i i m ^ i m ^ (One stop service) l l l l l iWlJloispllf a HIV/AIDS m ? f i s i j u i i i m i l p i

hu in^ianjjfTsfnn n f i n i mi^iioonminiiTiiiw?! 'nil'HwilQol.jjnnspiiTpi pfiwuofifia^nilQoimsia^n^io

4.2 ^ m i m i ^ n ^ i f n y n w i J i o m uinfui ia^pin! ) mnmmniliumi^Q m v /AIDS i i n i u a ^ a i m f n

13.00-16.00 M. m min i n Dniisj in i -nuti l JJ i mmo i^oiinfi(wilis;mu4nv!) md^iffii mzi imn ^mmn

4.3 if^imijliimifnyifli jIiJadi^mjjistTiJuasij^iTniPiii^viiinonia^ni dn w i l i o f l CD, <200 ceiis/dL q qj q q q i 4

fnil;?l11l01 Co-trimoxazole iJa^iHVIlJaSfianitril'KC^ Pneumocysticjiroveci pneumonia (PCP) 111 u l l U fllfimii^im 14011

m d ^ ' i f n i l ( ? i d 4 t m i i l i i w i ] i o l ^ i i i n i i i n y i ^ i o o i i ] a 4 n ^ f f i u l n d r f ^ t m u m i l ' l f o i Dapsone m a

Co-tiimoxazolella^nuilafiafltlllllfCplPCP 4 0 n o t T 4 i m } j m i l l o i Fluconazole l la^nu Ciyptococcal meningitis 20110

5. iT i i i i io i J i l i l t i l i J imi iedi^i i ' a i in^ium^if f i i i J i^ iuau 'n i i i u ^luuiinmm^md^'Bniijjwiliolio'HSpi ^lu

n i i i i f i v n ^ m ^ i f n i i w w i l - i o l i a i i n i n i u ^ l u u i i i i c i i n ^ m d ' w i i u w i l Q o l i f i T ' m l i f i i i l u ^ u

6. i i i lwmiJ iA j i j a i i i J i i inw^nyiv i iamd' i fml i j l i^ i^o i i i i f iuas i l iw^^^

gi4oiiimittiBiimi|nj?ii4nliimnpi^ii4nai4i3Jo ^^iSi jnii iN^iiimonTOijaoiriiadi^piama^tmsti ' i JWija i i i l i i

w i l i o HIV/AIDS l ^ i u n i i i n i i i ^tm'Ml?iiJiPiif i w i R i o m i d ^ m i i i J i ^ i ^ ^

7. m i g t m w i l i o HTV/AIDS ^a^flniiPjtm^iSiJ^iJtriitTiniiQwi^ufisiiinaiJiQjJinwd^ifnil^^^

tmsiin niisu94^iiia4adi4=KPiwi4li!niifj traNi] im tas^a^C m i i l i s i i n i i ^ i u ^ ^ n u ^ ufTinnlifiSvilumig uawiJ -30

8

Riliejinpifmwiiw^g^^lijmillm imsimniiJSejwilEJUilijndjJwiJio i\ml^ml^\m\nmm\.m^i\lmlmu qj qj q qj qj qj

5s;v!-3iw3JtTvianTJii=BnliN W^iufiwiJQOimiia^miiJiiJjfiiiwiJifj •M^SmiuandScjuil'as^tnjfnim fniufis^n-ii^nvi qj qj qj q*

d ICS o / ^ q I I I Q ^ i t f ' q rf-^ai q j / j = a i i q q j /

uranfiiim-vn^miilgii?! m u n miinom 2 trilmvi Imifj'ntn^iltijvnmibm fnisjtnvinjjmmibmnis-a

ua2;ft4tm }jmillm0m4m3Jis;?riJ'^^tremfi mnijniii^^i4i4iiJ9 m o

q

8. miiliM'tf'iJ'ssi'ki'W'y

2. muvjuoinuf i i f iN^nun m 0 m ^ i f n i l i 4 l i 4 ' v ^ m i n f i u f i s ; l i w m i n 0 0 u n liid^^n^pi^iufiniiimvio nuin^

4. i,ilpiiiviiii\niinys;mi^ni.'ui44iynj04md^Tfnilm9i4^O93jfiin)04'M

5. mwiJisi mwpiopiwio^ mminis;^'U0'3iJj^w^i 0i40nm0iJis;tew mmiilgu^-aiu onsjnnviijn m

1.1 min)nfi0iiaj^4li)0m4uyi!)i4lijnii!'iJiJis;yiiT4m mi^3JiiiilisynwajjneniDiJij;Ynum mniifi

oniiml^inoifiiimiintn SilflivntTnifiTMiminwiJ I'lfiJ n^iimdiinn 11103111 1 0111111101010 imswiliol3nfii

1100011111)141 m will 0 i i H n m m ©in iil f y m n i i i inlisniuoi m ©^^inn 4i0ims0010 m-u

1.2 wiJ-ioii3J9i0ifi4li)m0iiiiJisiiii4Oiili!n0iiJiij i t p l o 4 l 3 m u w 0 n i i i n i n

1.3 0i iw0iiw^Pi00111 n y i niiguatimo™ 1110 limniiiouinmmiiuunii-aiJgiiPiprai u w u n i n n y i

1.4 min ) i f in i i inui t i i i0 iv i^m^041^0 f iitin lloiiirviipi

1.5 wiliolwtnuiioiiiiiioi^iuir^

1.6 iJfuiiiflillflio liiilijlijniiiniJi m04!)inwilQooi0i)u 1334iiiiiinn^iiols?i 1.7 WlJ lolli 90101)1^411114 1.8 0191101 itn?)0niiri9i.m 13tiiTiifti4i4imsifiom^9

1.9 13SNVIIWIJIOUIII)OI

9

1.10 wiJieitTiJfiimfiioi Ifionnpifmji^^l!)!)?^ in^njimg-umQ^iiifiisutT

1.11 wi]iolpifii'U9iiiiBin0iji9ii=iii4m0!)in^9inoQnijnii

2.1 enf l i ianonjui^Simni lu '^

2.2 hiiimilmmzmmn mzmA'sn<f\mm<F\h^

2.3 inpigimiiii^mminnmgEJi^sjin "HIain^fmimm

2.4 1111)111 111140104010 tifu oiiii4if'Ufi^04fisfiioiiiifi4raiiDilis;iiiiiljitTs;f)'in iiiii nauoinii

VI04011111 !fi9ri94'114 l l l u ^ U

3. iffuvii^ineiflinifOTainEJiniJisiiJijmifijIniiijasjNdgi^

3.1 ilfyiiinj04is;iiiii)iniiliiniiiJinDi Imn t i o i i j ^ l i i n i i i l i n u i l i J m D r f r D ^ 00111^ fioolmi 04^

tilui]tiJiii«S'i)'if0ii will iiiniiiJini)in)ifiniil'liiniJs;uasiJis;^i)niim1ijnii 111 0111^

3.2 ' i i 0 l i i i ^ D 9 4 i s ; i i U 0 i i i i i 0 i i I m i f i mi i l^^n! ) f tn ) 0 i v i n i i i l p i D i i i i o i u ? i s ; m i l i i 0 i i l i n u i '$4liJ q

tizmnm wiJio dxi niii lfilwi4n0i^^94iii4ii4 0 i i d 0 o u w i i i i 4 i ^ v ( i 9 ^ u 4 i u iiiliiDifi0iiu?i0m04 ^ i iw qj qj

liiiiiniiliil'95U0l3J?ii4nij i i i W w i l i o i n^onud^ i i t n j t i lul i i i

3.3 ^U4114miSpl1SllDnili?)^1UWlJ'3O0dl4?i0l'U04 qj

3.4 n)9!)ins?ilv!0ii^nT)iPiiii4ii04iJgii^nii i i i04 ! ) i0N0ii i4i i04i lgi i^mii i i4i l is ;mii mtnunopin!) m

mn 1^11l=U9110ll dli IS^DOindu aminoglycoside 01 CD^tllw^U

3.5 0iiJiiUfisii0iis;n)04wiJgii?i4iii3jnj0!)i0Pi m04T)inilistiD0iitun)04mfruni nmzm m m i n u

3.6 niiiJisifi0 iii ii4B U0s;niio0uiiiii94imiio iJ00iniiii4miimiio^0mW0i

3.7 0 n u i 111^01)04^1]iou0s;fi)i^ m04i)intiJii tms wiJ 101114110 ljJlii0iiJiii3jS0li4niiiDDi0ii

H I 0lii ¥1111)1111 014

d a. 3 / 3 / 0 / 0/ ^ 3 ^ 1 = 5 a/ i . ^ | £ a oy^^

1.0111) ni i tpi i 011011111 10iifi 114Y1 nws;D04miTimi i ms;ftn'yi4iii?i luiii in0vn4mtrifni i i i09i!m uijg 11 4111 QJ O QJ£=i 3/ <=. QJ q f\ t ^

2.011!) p)n i u u i i i i 4 m i i l g 11 PI 41UPI l u n i i D i i i i 0 i i i 4 m i i i f n i i wimsvi 1114111 mwiJ 1000 iiu mnn) u

3.0ii3niiilisifi0^iii^iU0stiii4is;i)ii4iuniiij0^110111140111 m i i o l i i 1100101^inoi4'04iiiiii04w?i^1102;

Wai^O ll044lV!ll1lllfl1114m0^mill

4.011m DiJ 00iniu0s;ii'^iiiffno0iiNiJ 0 0 i n i l i i ti0f)00 04riiiiJi 3Jim4iij|'iuS l i T i i i n f l u

10

c141f9 ^ 3/ c i

wn)9iumiilismv!

lp iPi i iT) i r9 i Juain)9 i i J i94 ' i iwf i4 iv i^4ndi i ' i i i4 l i Jonpi^

04159 i/yr. „ ZZ7. 04=K9 y

v!'3'Huin03J4nijmtT=Kni'3jj /..... .../

n0'u0nini)Pini4iiimi'vi^ogSis;^ijpf4

nd3J4Tum^=Kn '3iu li4V^ejTLn0nifmifuoifTfi

^ ...Lm.MM ^

^QitfUQ mim ifiniimevT^iii^i'wl'HSiJisHiiiiii'Mwin^w

m9disn9ijniiupi4(n-a1'H(aii4mii'H'u'-3 md^wi^BTunami (mmnmn-i^mmn)

l i ^ v i o i u m n O T i i m o i f r j j m-ummmm

V H I q qj

qj U q

2. w i l i o H f j i ^ T u i i J i n n 9/ M q 3/ in 1 a '

3. WTJIOIOTI mofipiB^

ilin tilupi'u l-awiJiEJiiQijlTidlii'viniitnm^ tms;Qi0niim1ii0nnii1}j'^4ilis;m0^mspifiulpiin4Mjji^

muM niiW0Qnijfif04nnillonufis9iniilw^4iJis;tT40^9i!ii0PiCi4fli0niillfjn ^JS-niKwiJiejlluilliadi^

ilisSviSfni^innniy

T'p|0lJl2iir4fJ1119l'l)THJJ1!J

1. m0liiwdioli0^pilpifiJ0iiiJismi4W00iilloin)94wi]iej0eJi40i0iJ00iJ

2. m0m3j0 -3 i3J i i3 j^0lv!miKoi it0S0^iltiJV(iinn0iilloinj94wiJioli0'H^

3. m00^0nlliiiopini4Oi^t0^?n0niiK£jn1iJmijns?ifij u0s;0pi0'iin%Ji0nstluiJiEJ^m^inn0nillEJT

4. m0iN^i4iYini)Sinj04mtTifni mmiilgupi^nij lijpnuoiiuiina'vn^mirwiijj imsii^^ui^nuuiina

yn4md^=Knii3jnj0400 '3J4ium0 'wiijj l i^vioninanwiiuiofffS

5. m0lmnfi0iiiii4niJi9iJ^iitTVitTinjniifi5i^u0Simfi0iiiN^i4i0inu

2

qi <U qj

t49n!)ini1ni5lTffiQi3jn\4niiHui!)s;=Kie)afiftinjJi^Jtii^n)9^9nniil3j'H-3iJ5s;m^^^

!nnmit?i5QD 'MiJi]arini)nnniiKyi!'nyilifi'HPi=u9-3wiJ'3ejlwli^'Maiiiifi pi S

1 . RiJ '3yHeji1piyl3Jyi5ii)-3ifinimpi9iniiM9i)'H^i)i^rif9l3J qj

2. NiJQEj1dviiiiJ'in9nniild '^^iJis;mR°'^mfiwiIi4in;RT)nnniille)i

3. w i ] i y ^iJ ? t i j l i 4 i l n i i l l t ) i ims ; l i J Y i i i i ) o ^QBni imi j ! 'nwit in^nn ^ 9 ^1 ( ? iE j% n qj qj qi '

4 . wiJlEJllfu'UU1?lEJni9^3^13Jm'3S;nj9-3ll9^m3jfi\4'Hf9aflf1^

annilfuviipi^fifin iJnSin^=Bni1iifiQn3jftinNiJQolijnjtus;tT-3}J9'ijyi ii^'m9-3i)inncn^^inpincij;wiliy1jj

o i i i a ' a / d / o / a ' l ' : ^ Q^-^i q a / £ ^ 3/ < 513/1113/

9e)n-3fjn^9^t'HuisfT3J3Jin?i4

1. ilis;wSii.i)-3Yii)yni4fniufli4fnilMiJifni wilitjli^'HSpiiiijniitm'vio'v^EJiijifiims;iJfifiini9t4 ^

qj

lii^iillriiJitmNiJ-iEJimj;iJfifnfigi-33Ji=KnS'iN

2. nivii4Piii]iviJJiyniimmwiJ-3£j'5QijriiJtm'viy

3. nivii4^imiyii-3nni^u?iwil'3ej'Hfii'3Jjniitmyio lAiyiinji

4. nTHUfiQBfml 'Hfni i j f l 'umi l lo i ims;^9^iiiJis;=Knd^3jiNiJBlif^3JTiiiij^^nn5iin^nv!ni9^md^=Kni

5. ^Pitmeijjl 'ayeioi ims;uiJutT9ucnufm3jfl^4milltn

6. ^?ini9^NiJ'3ej ufisiHrniufuicivn-jm^OTiiu lfiejimlnj!]fiJViiniillt)nnj9^NiJQmm'as;iiyTn^l'u

11 ^ IN 01 111 ?i 11 a s i SPI ?n w I ? EJ u 11 n u

7. mij4'9yiiUfis;'uimt49 itfi^uuviyiy uai;"Hmuna m 9 i J i u i J '3-3nis; iJ iumii i i^TU

9. imriiiJaoyilyijfmifiiiawiJiejnii^utmyio uasvitnuici

3

1. wi)iylifi'Hf)1piiiJfin?il53^m\4N?iriniHyi9EJi-3fi50i)fi^iJ im m4mm^^iif]m'^\^ui niiiiimm

3. ?ififiilli)nypi™£)i^mfi!)inniillEJilij 'ivi3jns;tT3j itcis^afifi 'iinwinnisi^iiil-iej^mfiiiinmiHEn

5. m f i f i i i i i i ' n w i ' - i u r i u t i l u ^ u ^ n ^ i n n i ^ n S i A i I m i n mminmm tmsnyiuiJ i • n n l ' H w i l Q e j I l f i j m i

fn^n^SaaifniAiijnnw

1 . finjjfpiiuEnnjQ-JNiJQfjlifi 'Hfi v i a ^ l i i 0 n i J l n y n m i i ^ \ 4 i i i n n ' i i n 0 i j l ' H ^ i ' i J l n y n

2. i0£ias;wiJQylia'HPi^tTiiJi?cifiiiJ9Jj0iniilm 'Mwflujjnnn'innoul^

3. m l l f l ' iEJEnnia - ^ w i J i E j l i f i ' H f i f i^ f i^

4. ?TUQi4Wi]iEjlifi'H^^l0^3jiu9'ufnyn^'3luli^'MEninfi m9^Tnnl3JtifiJjnicifnu^}j0imilpi mv\^

in v

wnj0iiiilisi5u

../...<?)ij.a.M?? /....